A Double-blind, Placebo-controlled Study of Lumateperone in the Treatment of Borderline Personality Disorder
Jon E. Grant, Sophie Boutouis, Laurie Avila, Megha Neelapu, Dustin Ehsan
Clinical Neuropharmacology · 2026
10.1097/wnf.0000000000000693